Does early sulfasalazine treatment provide long-term benefits to patients with juvenile idiopathic arthritis?

被引：0
|
作者：
Tracy V Ting
Daniel J Lovell
机构：
[1] OH,TV Ting is a 2nd year Pediatric Rheumatology Fellow and DJ Lovell holds the Joseph E Levinson Chair in Pediatric Rheumatology and is the Associate Director of the Division of Rheumatology at Cincinnati Children's Hospital Medical Center in Cincinnati
[2] USA.,undefined
来源：
Nature Clinical Practice Rheumatology | 2008年 / 4卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The small, well-designed, observational study by van Rossum et al. raises and addresses questions of great significance for the treatment of children with JIA. The original RCT demonstrated significant benefits of sulfasalazine over placebo that, by today's standards, would be considered only moderate clinical improvement. Despite these initial modest effects, the sulfasalazine group demonstrated improved outcomes compared with the placebo group 9 years later.
引用
收藏
页码：344 / 345
页数：1
相关论文
共 50 条
  • [1] Does early sulfasalazine treatment provide long-term benefits to patients with juvenile idiopathic arthritis?
    Ting, T. V.
    Lovell, D. J.
    Levinson, Joseph E.
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2008, 4 (07): : 344 - 345
  • [2] Long-term outcome of juvenile idiopathic arthritis following a placebo-controlled trial: sustained benefits of early sulfasalazine treatment
    van Rossum, Marion A. J.
    van Soesbergen, Renee M.
    Boers, Maarten
    Zwinderman, Aeilko H.
    Fiselier, Theo J. W.
    Franssen, Marcel J. A. M.
    ten Cate, Rebecca
    van Suijlekom-Smit, Lisette W. A.
    Wulffraat, Nico M.
    van Luijk, Wilma H. J.
    Oostveen, Johanna C. M.
    Kuis, Wietse
    Dijkmans, Ben A. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (11) : 1518 - 1524
  • [3] Long-term outcome of juvenile idiopathic arthritis following a placebo-controlled trial: Sustained benefits of early sulfasalazine treatment.
    van Rossum, MA
    van Soesbergen, RM
    Zwinderman, AH
    Boers, M
    Dijkmans, BA
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S86 - S86
  • [4] Long-term outcome in patients with juvenile idiopathic arthritis
    Minden, K
    Niewerth, M
    Listing, J
    Biedermann, T
    Bollow, M
    Schöntube, M
    Zink, A
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : 2392 - 2401
  • [5] Long-term prognosis of patients with juvenile idiopathic arthritis.
    Minden, K
    Niewerth, M
    Listing, J
    Zink, A
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S119 - S119
  • [6] IS EARLY TREATMENT WITH BIOLOGICS ASSOCIATED WITH A BETTER LONG-TERM OUTCOME IN PATIENTS WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS (JIA)?
    Klotsche, J.
    Minden, K.
    Niewerth, M.
    Seipelt, E.
    Hammer, M.
    Zink, A.
    Horneff, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 739 - 740
  • [7] The Long-Term Outcome of Juvenile Idiopathic Arthritis
    Ravelli, Angelo
    Martini, Alberto
    CURRENT RHEUMATOLOGY REVIEWS, 2005, 1 (02) : 151 - 155
  • [8] Long-Term Safety of Etanercept in Patients with Juvenile Idiopathic Arthritis (JIA)
    Minden, Kirsten
    Niewerth, Martina
    Klotsche, Jens
    Hammer, Michael
    Haas, Johannes Peter
    Ganser, Gerd
    Horneff, Gerd
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S493 - S493
  • [9] Shoulder arthroplasty in patients with juvenile idiopathic arthritis: long-term outcomes
    Marigi, Erick M.
    Lee, Dustin
    Marigi, Ian
    Werthel, Jean-David
    Barlow, Jonathan D.
    Sperling, John W.
    Sanchez-Sotelo, Joaquin
    Schoch, Bradley S.
    JOURNAL OF SHOULDER AND ELBOW SURGERY, 2021, 30 (12) : 2703 - 2710
  • [10] Long-term outcomes and predictors of outcomes for patients with juvenile idiopathic arthritis
    Oen, K
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2002, 16 (03): : 347 - 360
12345